OptiBiotix Health (LON:OPTI – Get Free Report) posted its earnings results on Thursday. The company reported GBX (1.52) earnings per share for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.
OptiBiotix Health Stock Performance
Shares of OPTI stock opened at GBX 5.98 on Friday. OptiBiotix Health has a fifty-two week low of GBX 4.50 and a fifty-two week high of GBX 12.25. The company has a market cap of £6.17 million, a P/E ratio of -1.56 and a beta of 1.82. The stock has a 50 day simple moving average of GBX 5.79 and a two-hundred day simple moving average of GBX 5.73.
OptiBiotix Health Company Profile
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products.
Read More
- Five stocks we like better than OptiBiotix Health
- Intel’s Ohio Lifeline? Why the SK Hynix Talks Matter
- Generac Plugs into Amazon for an $8B AI-Powered Deal
- Laser Focus: 2 Optical Stocks Lighting Up AI
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}